← Leaderboards
Ryan Thomas Hurt
Mayo Clinic Rochester
$1,152,158
Attributed
$1,358,127
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $411.9K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,358,127 · 2
By mechanism
K23$946,188 · 1
R21$411,939 · 1
Top collaborators
- Ivana Tallerico Croghan1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Victor M. Karpyak$3,624,336
- Ivana Tallerico Croghan$205,970
Others in their field
Top investigators on “Randomized”
- James Dennis Neaton · Northwestern University$305,243,252
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$292,521,996
- Lawrence Corey · Fred Hutchinson Cancer Center$292,521,996
- Marian Ewell · The Emmes Company, Llc$278,931,253
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$199,647,509
- Beth Baseler · Leidos Biomedical Research, Inc.$194,920,310
Research focus
RandomizedUnited StatesNicotine ReplacementPharmacotherapySmokingTobacco AbuseClinicNeuronsObesityPharmaceutical PreparationsSmokerAnimal ModelFda ApprovedSmoking CessationAddictionBupropionInnovationMorbidity - Disease RateCigarette SmokingHealth Care CostsCigarette SmokerParticipantRelapseVarenicline
Grant awards (6)
Using Vagal Nerve Stimulation in Conjunction with NRT for Smoking Cessation$411,939
R21 · FY2025 · CA · contact PI
Varenicline and lorcaserin for smoking cessation and weight gain prevention$196,128
K23 · FY2019 · DA · contact PI
Varenicline and lorcaserin for smoking cessation and weight gain prevention$196,128
K23 · FY2018 · DA · contact PI
Varenicline and lorcaserin for smoking cessation and weight gain prevention$196,128
K23 · FY2017 · DA · contact PI
Varenicline and lorcaserin for smoking cessation and weight gain prevention$178,902
K23 · FY2016 · DA · contact PI
Varenicline and lorcaserin for smoking cessation and weight gain prevention$178,902
K23 · FY2015 · DA · contact PI